Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Pricing ‘Solutions’ Coming In Future Phase Of US Healthcare Reform, Sec. Price Says

Executive Summary

Trump tweets about plans for 'new system where there will be competition' to address Rx costs as Republican effort to repeal and replace the Affordable Care Act officially gets underway with release of two House bills.

You may also be interested in...



Trump's Greatest Hits: Drug Price Controls As Part Of The Repertoire

President's pledge to merge drug pricing control with a revamp of the Affordable Care Act wins applause at Kentucky rally, where the president reeled through a number of his populist issues, even as the idea makes scant legislative progress.

'Repeal And Replace' Going Relatively Well For Pharma So Far

US White House game plan for repealing and replacing the Affordable Care Act includes a proposal for faster generic drug approvals but no direct government price controls.

It’s Complicated: Health Care Act Simplifies Buying OTCs With Pre-Tax Accounts

CHPA gives tempered support for White House-backed legislation to replace the Affordable Care Act because it would eliminate requirement that consumers can only use pre-tax savings accounts for OTCs if they have a prescription.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS120179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel